Doctor Explains Antidepressants: What the First 8 Weeks Should Feel Like

The first weeks on an antidepressant feel wrong in ways that nobody adequately prepares patients for.

You started because you wanted to feel better. What you got instead was nausea in the morning, a strange restlessness in the afternoon, and sleep that is suddenly lighter than it was. Your mood has not improved. You cannot tell if the medication is doing anything. The rational conclusion, in the absence of any other information, is that it is not working.

That conclusion is wrong in most cases, and acting on it, by stopping the medication before it has had a real chance, is how antidepressant trials fail before they are complete. Approximately one in three patients stops their antidepressant in the first month, usually because side effects arrive before benefits do. Every one of those early stops is a lost trial that gets entered in the medical record as a failure.

Here is what is actually happening during those eight weeks, week by week, and what to do with that information.

Why Antidepressants Take Time to Work

Antidepressants begin affecting brain chemistry within hours of the first dose. Peak plasma concentrations of an SSRI like fluoxetine are reached six to eight hours after ingestion. The medication is pharmacologically active essentially immediately.

The problem is that pharmacological activity at the receptor level is not the same as clinical antidepressant effect. As reviewed in a comparative analysis of antidepressant timing published in Current Neuropharmacology, the neuroplastic changes associated with mood improvement, including receptor sensitivity adjustments, downstream signaling shifts, and structural changes in brain circuitry, require weeks to complete. Currently available antidepressants take weeks to months to achieve their full effects.

This delay between pharmacological action and clinical response is the structural source of early discontinuation. Side effects are a direct result of the pharmacological action. Benefits are a result of the neuroplastic changes that follow. The timeline means you experience the cost before you experience the benefit, and if nobody explains that in advance, the rational response is to stop.

Weeks 1-2: The Hardest Part

This is the period most likely to produce a premature stop. Side effects are at or near their peak. Mood improvement has not yet appeared.

What to expect in weeks one and two:

• Gastrointestinal side effects. Nausea is one of the most common early side effects of SSRIs, particularly sertraline and escitalopram. It is typically most prominent in the first week and resolves for most patients by week two to four. Taking the medication with food reduces the intensity for most people.
• Activation or restlessness. Some patients experience increased anxiety, jitteriness, or a sense of being revved up that is distinct from their baseline anxiety. This activation effect is common with fluoxetine in particular. It is transient in most cases and resolves within the first few weeks.
• Sleep disruption. Antidepressants can affect sleep architecture, producing insomnia, more vivid dreams, or lighter sleep in early weeks. This often normalizes as the body adjusts, though it can persist for some patients and warrants discussion with your prescriber.
• Headache. Common in the first one to two weeks, typically resolves without intervention.
• Wired-but-tired sensation. A specific and common early experience in which you feel physically activated but mentally fatigued. This is a transitional state that does not persist.

What not to expect: any meaningful improvement in mood. Week one and two improvements, when they occur, tend to reflect early shifts in sleep or energy rather than direct mood improvement. Data from multiple large-scale studies suggest that antidepressants can lead to improvement within the first week for some patients, but these early changes are in energy and physical symptoms, not in core mood pathology.

Important safety note: Oregon Health Authority clinical guidance on antidepressant initiation notes that antidepressant medications can increase risk of suicidality during the first few months of treatment, with this risk more prominent in adolescents and young adults. If you experience worsening depression, new or increased thoughts of self-harm, or suicidal thoughts after starting an antidepressant, contact your prescriber immediately, call 988, or go to the nearest emergency room.

Weeks 3-4: The Transition Window

This is where most patients begin to feel the early shift. It is rarely dramatic. More often it is the absence of something: the nausea that was there every morning is gone, or mostly gone. The sleep is closer to normal. The restlessness has settled.

What to expect in weeks three and four:

• Side effect resolution for most patients. Most side effects will improve or resolve entirely within the first two to four weeks on each antidepressant. If significant side effects are still present and worsening at week four, that warrants a conversation with your prescriber about dose adjustment or medication change.
• Early functional improvements. Sleep quality, appetite, and energy are often the first symptoms to improve, sometimes appearing as early as week two or three. These are meaningful clinical signals even before mood has changed directly.
• Possible subtle mood shifts. Some patients notice a reduction in the worst days. The floor of their mood has risen slightly. This does not feel like being better. It feels more like not being quite as bad, which is the medication beginning to work.

The most important thing to watch for at this stage: whether you are building a consistent dosing habit. Skipping doses during the first four to six weeks of treatment delays brain adjustment and extends the period of incomplete response. Every missed dose during the first four to six weeks delays brain adjustment and extends the rough period.

Weeks 5-6: Where Most People Notice Something

For most patients on SSRIs or SNRIs, meaningful mood improvement becomes noticeable between weeks four and six. This is where the clinical benefit that the medication was always building toward becomes subjectively apparent.

A pooled analysis of fluoxetine trials found cumulative response rates of approximately 48% by week six, rising to over 80% by week eight. Separately, approximately 50% of patients show early improvement by week two, with sustained response maintained through week six.

What improvement looks like at this stage is often different from what patients expect. It is not a sudden lifting of mood. It is that the things that felt impossible feel less impossible. Getting through the work day is easier. Social situations that had become draining are slightly more manageable. You might find yourself laughing at something and realizing it has been weeks since that happened.

This is also the period of a critical clinical risk. Feeling better does not mean the medication is finished working. It means it is working. The patients most likely to stop their antidepressant prematurely are not the ones who did not respond. They are the ones who felt better and concluded they no longer needed the medication.

Weeks 7-8: Full Therapeutic Evaluation

By eight weeks at an adequate dose, a prescriber has enough data to evaluate whether the medication is working at the current dose and whether any adjustments are indicated.

Clinical guidance notes that if no progress is seen after eight weeks, the provider should consider dosage changes or medication switches, as full effects are typically present by this point for most patients.

Full response at eight weeks means significant symptom reduction, typically defined as a 50% or greater reduction in symptom severity scores, with remission meaning fewer symptoms and return to baseline functioning. Partial response, meaning some improvement but not full remission, is the clinical signal for dose optimization before switching medications.

If you have been on an antidepressant for eight weeks at the same dose and feel no meaningful change, this needs to be discussed with your prescriber. The options at this point include dose escalation, medication switch, or addition of an augmenting agent, each with a different evidence basis depending on your clinical picture.

Early Response as a Predictor of Remission

Early improvement in the first two to three weeks is not just reassuring. It is clinically predictive.

Individuals achieving 20% or greater symptom reduction by weeks two to three are likely to reach stable response or remission later. A controlled trial found that those without early gains had a very low chance of later remission. This means early response is a highly sensitive predictor of eventual outcome.

The clinical implication: if you are in the first two to three weeks and notice any functional improvement, even subtle, this is meaningful data that the medication is beginning to work. Track it. Report it to your prescriber. It is a signal worth monitoring.

Conversely, if there is no detectable change of any kind by week three or four, including in sleep, energy, or concentration, this is also meaningful data that warrants discussion with your prescriber rather than waiting until the full eight-week window has closed.

What to Watch and When to Call Your Prescriber

Contact your prescriber immediately if:

• You experience worsening depression, new or increased suicidal thoughts, or thoughts of self-harm after starting treatment.
• Side effects are severe enough to interfere significantly with daily functioning and have not improved after two weeks.
• You develop a rash, hives, or other signs of an allergic reaction.
• You experience unusual behavioral changes, agitation, or hostility.

Contact your prescriber at a routine appointment or message if:

• Side effects are bothersome but not severe and you want guidance on management strategies.
• You are at week four to six with no detectable improvement in any symptom domain.
• You have been consistent with medication but feel unchanged at week eight.
• You are feeling better and wondering whether you can stop.

How SiggyMD Monitors the First Eight Weeks

The first eight weeks of antidepressant treatment are when monitoring matters most. Side effects need to be caught and managed before they produce premature discontinuation. Early response signals need to be identified and reinforced. Dose adequacy needs to be assessed at the right time, not three months after the window for early adjustment has passed.

SiggyMD's daily check-ins during this period capture the temporal data that makes real-time clinical decisions possible. Side effect severity by day, sleep quality by night, mood trajectory by week. When a side effect pattern suggests that dose adjustment or management guidance would prevent early stopping, the prescriber has the data to act on it before the patient has already decided to discontinue.

"The first month is when I need to see the most data," says Daniel Montville, MD, Psychiatrist at SiggyMD. "The patients who stop in week three usually stop because nobody was watching what was happening to them. The nausea peaked and they had no context for it, no one to check in with, and no reason to believe it would resolve. When I have daily data, I can see the side effect trajectory, message the patient with what to expect, and keep the trial running through the hardest part. The medication often works. The gap is that nobody was there to see them through the first three weeks."

What Members Are Saying

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

Frequently Asked Questions

When Will I Feel Better on an Antidepressant?

Functional improvements including sleep quality, energy, and appetite often appear within one to two weeks of starting treatment. Mood improvement typically becomes noticeable between weeks four and six for most patients, with full therapeutic effect by weeks six to eight. Individual timelines vary based on medication type, dose, metabolism, and the specific symptoms being treated. If you have no detectable improvement in any symptom domain after four to six weeks at an adequate dose, discuss this with your prescriber rather than waiting for the full eight-week window.

Is It Normal to Feel Worse in the First Weeks on an Antidepressant?

Some patients experience a temporary increase in anxiety, restlessness, or activation in the first one to two weeks, particularly on activating antidepressants like fluoxetine or sertraline. This is a recognized early side effect, not evidence that the medication is wrong for you. It typically resolves within two to three weeks. However, if you experience a significant worsening of depression, new suicidal thoughts, or severe mood instability after starting an antidepressant, contact your prescriber immediately or call 988.

Can I Stop My Antidepressant if Side Effects Are Too Difficult?

Do not stop abruptly without prescriber guidance. Abrupt discontinuation of SSRIs can cause antidepressant discontinuation syndrome, including dizziness, nausea, and flu-like symptoms. Discuss side effects with your prescriber before making any changes. Many early side effects can be managed through timing changes, dose adjustments, or temporary management strategies that allow the trial to continue through the side effect window.

How Do I Know if My Antidepressant Is Working?

Look for functional improvements before emotional ones. Better sleep, improved energy, easier concentration, and finding it easier to get through daily tasks are early signals that the medication is having an effect, even before mood improves directly. Feeling "not quite as bad" rather than actively better is a clinically meaningful early signal. Tracking these changes daily makes them visible; relying on memory at a follow-up appointment underestimates how much progress has occurred.

What if My Antidepressant Worked at First But Then Stopped?

This is called antidepressant tachyphylaxis and is a distinct clinical phenomenon from treatment failure. If you responded well initially and then experienced a gradual return of symptoms despite consistent medication use, discuss this specifically with your prescriber. The clinical approach to tachyphylaxis differs from the approach to a medication that never worked. Options include dose adjustment, augmentation, or switching medication class, each with a different clinical basis depending on your situation.

Bottom Line

The first eight weeks of antidepressant treatment follow a predictable sequence: side effects before benefits, functional improvements before mood changes, and gradual symptom reduction that looks nothing like the immediate relief most patients expect.

The patients who complete this eight-week window are the ones who had enough information to stay with the medication through the hardest part. The patients who stop in week two or three are the ones who did not know what was coming, had no one monitoring how they were doing, and made a rational decision with insufficient information.

The monitoring structure around those first eight weeks determines outcomes as much as the medication itself.

Sources

1. Baldessarini RJ. The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments. Current Neuropharmacology. 2014;12(5):444-454.
2. Oregon Health Authority. Starting Antidepressant Medications: Clinical Guidance. Oregon OHA. Accessed May 2026.
3. Pillo.care. Starting antidepressants: a week-by-week guide to the first 3 months. Accessed May 2026.
4. Dignity Brain Health. How Long Do Antidepressants Take to Work? A Step-by-Step Timeline. 2025. Accessed May 2026.
5. Marley Drug. What to Expect During the First Few Weeks on Antidepressants. Accessed May 2026.
6. Footprints to Recovery. How Long Should Antidepressants Take to Work? Accessed May 2026.
7. Lewis G, et al. Maintenance or Discontinuation of Antidepressants in Primary Care. New England Journal of Medicine. 2021;385:1257-1267.
8. Semahegn A, et al. Psychotropic medication non-adherence and associated factors in patients with major psychiatric disorders. Systematic Reviews. 2020;9(1):17.